Zacks Investment Management Alkermes Plc. Transaction History
Zacks Investment Management
- $11.4 Billion
- Q3 2024
A detailed history of Zacks Investment Management transactions in Alkermes Plc. stock. As of the latest transaction made, Zacks Investment Management holds 69,531 shares of ALKS stock, worth $1.93 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
69,531
Previous 64,277
8.17%
Holding current value
$1.93 Million
Previous $1.55 Million
25.63%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$806 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$526 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$360 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$351 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$254 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.55B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...